Back to UBS Group AG UBS Group AG

CADLCADL
20 quarters

Position history for UBS Group AGUBS Group AG's holdings in CANDEL THERAPEUTICS INC

UBS Group AG holds 169,271 shares of CADL (CANDEL THERAPEUTICS INC), worth $1.7M as of 2026-Q2. The position was increased (+13.0% shares). CADL represents 0.0% of UBS Group AG's portfolio.

Current Value

$1.7M

Current Shares

169,271

Total Value Change

+$1.7M

Total Shares Change

+166,271

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
169,271
+13.0%
$1.7M0.0%$10.30
29
2026-Q1
Increased
149,855
+43.6%
$734,2900.0%$4.91
33
2025-Q4
Increased
104,339
+10.9%
$589,5150.0%$5.71
27
2025-Q3
Increased
94,071
+14.5%
$479,7620.0%$5.40
27
2025-Q2
Decreased
82,167
-56.1%
$415,7650.0%$4.90
0
2025-Q1
Increased
187,094
+19.3%
$1.1M0.0%$5.95
30
2024-Q4
Increased
156,806
+1560.0%
$1.4M0.0%$7.95
41
2024-Q3
Increased
9,446
+57.3%
$65,4610.0%$7.21
20
2024-Q2
Increased
6,005
+600x
$37,2310.0%$6.20
22
2024-Q1
Decreased
10
-99.9%
$160.0%$1.58
0
2023-Q4
Increased
11,921
+1191x
$17,5240.0%$1.47
20
2023-Q3
Unchanged
10
0.0%
$90.0%$0.92
0
2023-Q2
Unchanged
10
0.0%
$130.0%$1.24
0
2023-Q1
Decreased
10
-98.7%
$140.0%$1.38
0
2022-Q4
Decreased
795
-81.0%
$1,4230.0%$1.79
0
2022-Q3
Increased
4,181
+9.8%
$13,0000.0%$3.20
13
2022-Q2
Increased
3,807
+90.3%
$12,0000.0%$3.39
19
2022-Q1
Decreased
2,000
-55.0%
$10,0000.0%$4.59
0
2021-Q4
Increased
4,447
+48.2%
$34,0000.0%$7.97
19
2021-Q3
New
3,000
-
$33,0000.0%$10.27
30

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used